- Medication Safety Officer and Consultant Pharmacist, University College London Hospitals NHS Foundation Trust; Director, UCLH Centre for Medicines Optimisation Research and Education and Honorary Senior Lecturer, University College London School of Pharmacy
- Experienced pharmacist and researcher
- Fellowship project aims to optimise the safety of antimicrobial prescribing for patients with known penicillin allergy
- 2016 Improvement Science Fellow
Yogini Jani is a Medication Safety Officer and Consultant Pharmacist at University College London Hospitals NHS Foundation Trust and an Honorary Senior Lecturer at the University College London School of Pharmacy. She is also the Director of the UCLH Centre for Medicines Optimisation Research and Education.
Yogini is a national and local leader in the field of medication safety and an expert in quality improvement, technology evaluation and developing medical education to improve safe prescribing practice.
Her research projects have investigated medication errors in acute care hospitals, care homes and paediatrics, and assessed the impact of innovations such as health information technology and electronic prescribing: ‘All the research projects I have been involved in have focused on improving health care and my key achievement has been the ability to interface research approaches with real-life clinical practice’.
Yogini led an influential quality improvement project on preventable dose omissions, which subsequently influenced the development and spread of the national medication safety thermometer.
During her Improvement Science Fellowship, Yogini will investigate how to optimise the safety of antimicrobial prescribing for patients with known penicillin allergy. The project will evaluate how allergy status affects antibiotic treatment and patient safety:
‘Allergy details, prescribing information and patient outcomes will be studied using electronic patient records and expert opinion. Additionally, health care professionals’ and patients’ understanding, perspectives and behaviours in relation to allergy status will be sought using interviews. Findings will be used to develop, test and implement strategies for improvement through the National Medication Safety Officer Network.’.